Structure-Function of Entamoeba Alcohol Dehydrogenase 2
Structure-Function of Entamoeba Alcohol Dehydrogenase 2
批准号:
6733593
负责人:
SAMUEL L. STANLEY
金额:
$30.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-05-01 至 2006-04-30
关键词:
DNA binding proteinHaemophilus influenzaeHeLa cellsbiological signal transductionchronic obstructive pulmonary diseaseglucocorticoidshormone regulation /control mechanismimmunofluorescence techniqueimmunoprecipitationinflammationintracellular transportmicroorganism culturemitogen activated protein kinasemolecular pathologynuclear factor kappa betaotitis mediapathologic processpolymerase chain reactionprotein protein interactionreceptor expressionrespiratory epitheliumrespiratory infectionssecondary infectiontoll like receptortransfectionwestern blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Nontypeable Haemophilus influenzae (NTHi) causes infections in chronic obstructive pulmonary disease (COPD) and otitis media (OM). Both are characterized by inflammation. The molecular mechanisms underlying NTHi-induced inflammation remain poorly defined. Our long-term objective is to understand the molecular mechanisms by which the inflammatory response is induced and regulated in NTHi infections. Our recent studies showed that NTHi strongly activates nuclear factor-kappaB (NF- kappaB) via Toll-like Receptor 2 (TLR2), a newly identified receptor for bacteria. Because TLR2 expression in airway epithelial cells is low and overexpression of TLR2 greatly enhances NTHi-induced NF-kappaB activation, we hypothesize that NTHi up-regulates TLR2 via a specific signaling network. Our preliminary results indeed indicate that NTHi strongly up- regulates TLR2 via a positive NF-kappaB pathway and a negative p38 MAPK pathway. Moreover, glucocorticoids synergistically- enhance NTHi-induced TLR2 up-regulation. These encouraging results have thus laid a solid foundation for further investigation of the molecular mechanisms underlying NTHi-induced TLR2 up-regulation (short-term objective). Aim 1. Determine the contribution of NF-kappaB activation to NTHi-induced TLR2 up- regulation by perturbing NF-kappaB signaling pathways. Aim 2. Determine the contribution of p38 MAPK signaling pathway to NTHi- induced TLR2 up-regulation by perturbing p38 signaling pathway. Aim 3. Determine the signaling mechanisms by which glucocorticoids synergistically enhance NTHi-induced TLR2 up- regulation by studying the effect of glucocorticoids on NTHi- induced activation of p38 pathway. Significance: Understanding the signaling mechanisms underlying NTHi-induced TLR2 up- regulation will not only bring new insights into the regulation of inflammation, but will also open up novel therapeutic targets for modulating inflammatory responses in COPD and OM. Moreover, elucidating the molecular mechanisms by which glucocorticoids enhance NTHi-induced TLR2 up-regulation will provide instructive information regarding how to use glucocorticoids more appropriately in the clinic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An Animal Biosafety Level 3 Laboratory for Stony Brook University
-
批准号:7872073
-
项目类别:
-
资助金额:$1417.96万
-
财政年份:2010
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE Administrative Core
-
批准号:7641628
-
项目类别:
-
资助金额:$55.86万
-
财政年份:2008
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Overall Career Development
-
批准号:7641691
-
项目类别:
-
资助金额:$66.24万
-
财政年份:2008
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Immunogenetics of Smallpox Vaccination
-
批准号:7641580
-
项目类别:
-
资助金额:$31.99万
-
财政年份:2008
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases (Development Projects)
-
批准号:7641692
-
项目类别:
-
资助金额:$62.03万
-
财政年份:2008
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:6698909
-
项目类别:
-
资助金额:$334.38万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:6908968
-
项目类别:
-
资助金额:$827.51万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:7020077
-
项目类别:
-
资助金额:$795.37万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:7207962
-
项目类别:
-
资助金额:$766.08万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:6797835
-
项目类别:
-
资助金额:$789.41万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
MRCE for Biodefense and Emerging Infectious Diseases
-
批准号:7594903
-
项目类别:
-
资助金额:$798.22万
-
财政年份:2003
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Structure-Function of Entamoeba Alcohol Dehydrogenase 2
-
批准号:6466309
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2002
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Structure-Function of Entamoeba Alcohol Dehydrogenase 2
-
批准号:6623491
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2002
-
负责人:SAMUEL L. STANLEY
-
依托单位:
Structure-Function of Entamoeba Alcohol Dehydrogenase 2
-
批准号:6890407
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2002
-
负责人:SAMUEL L. STANLEY
-
依托单位:
ENTAMEBA HISTOLYTICA ADH2--A NEW TARGET FOR ANTI-AMEBIC THERAPY
-
批准号:6099926
-
项目类别:
-
资助金额:$10.76万
-
财政年份:1998
-
负责人:SAMUEL L. STANLEY
-
依托单位:
ENTAMEBA HISTOLYTICA ADH2--A NEW TARGET FOR ANTI-AMEBIC THERAPY
-
批准号:6235345
-
项目类别:
-
资助金额:$9.83万
-
财政年份:1997
-
负责人:SAMUEL L. STANLEY
-
依托单位:
PROTECTIVE IMMUNITY TO ENTAMOEBA HISTOLYTICA INFECTION
-
批准号:2671354
-
项目类别:
-
资助金额:$6.47万
-
财政年份:1994
-
负责人:SAMUEL L. STANLEY
-
依托单位:
PROTECTIVE IMMUNITY TO ENTAMOEBA HISTOLYTICA INFECTION
-
批准号:2057405
-
项目类别:
-
资助金额:$6.35万
-
财政年份:1994
-
负责人:SAMUEL L. STANLEY
-
依托单位:
PROTECTIVE IMMUNITY TO ENTAMOEBA HISTOLYTICA INFECTION
-
批准号:2517109
-
项目类别:
-
资助金额:$6.43万
-
财政年份:1994
-
负责人:SAMUEL L. STANLEY
-
依托单位:
PROTECTIVE IMMUNITY TO ENTAMOEBA HISTOLYTICA INFECTION
-
批准号:2057406
-
项目类别:
-
资助金额:$6.39万
-
财政年份:1994
-
负责人:SAMUEL L. STANLEY
-
依托单位:
海外基金